The Eribulin Mesylate injection is indicated for treating patients diagnosed with metastatic breast cancer (mBC) who have undergone at least two rounds of chemotherapy for managing metastatic disease
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
